Drug diversion prevention company ANiGENT has added a hospital leader to serve on its Board of Advisors (BOA). Kenneth J. Mishark, MD, from Mayo Clinic Hospital in Arizona, will sit on the board and provide insights on how ANiGENT can better serve healthcare organizations.
“Dr. Mishark will be an invaluable asset to our board,” said V.C. “Jun” Fabella, Jr., chief executive officer and managing partner of ANiGENT. “His expertise in leadership and experience overseeing a hospital drug diversion prevention program will allow us to enhance our platform and further prevent drug diversion.”
ABOUT ANiGENT
ANiGENT, is a company that delivers a comprehensive, patent pending solution Medication Administration & Analysis Program (MAAP). Created by chief product officer and managing partner Charles D’Amato, MAAP Analytics uses machine learning to deliver a state-of-the-art drug diversion surveillance system. For more information, visit: anigent.com
